IQ U.S. Mid Cap R&D Leaders ETF
MRND
MRND was delisted on the 12th of December, 2023.
1 hedge funds and large institutions have $4.04M invested in IQ U.S. Mid Cap R&D Leaders ETF in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
8% more capital invested
Capital invested by funds: $3.74M → $4.04M (+$301K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.53K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NYLIM
1
New York Life Investment Management
New York
| $4.04M | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| – | -$9.53K | -486 | Closed |
|
MRND Hedge Fund Activity: Q1 2023 in Review
1 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in IQ U.S. Mid Cap R&D Leaders ETF (MRND) for Q1 2023, worth a combined $4.04M — up 8% from $3.74M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MRND and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $9.53K sold.
- 1 institutional investor held IQ U.S. Mid Cap R&D Leaders ETF (MRND) as of Q1 2023, down from 2 in Q4 2022.
- Funds reported $4.04M of IQ U.S. Mid Cap R&D Leaders ETF stock for Q1 2023, up 8% quarter-over-quarter.
- 0 funds opened new IQ U.S. Mid Cap R&D Leaders ETF positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest IQ U.S. Mid Cap R&D Leaders ETF seller in Q1 2023 was UBS Group, an estimated $9.53K sold.
Based on aggregated 13F filings for Q1 2023.